Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
CRDF is at a double support currently. Could be a really good buy in point here. Don't be afraid to buy in small portions. 1st target is $15 to see if we get past that natural resistance. Options could be a possible way to go as well. Also, don't forget Cardiff is speaking at a virtual presentation on February 17th.
NASDAQ:CRDF Possible Scenario: LONG Evidence: Price Action, Reversal Candlestick, Unusual option activities for Feb 19 at 20$ TP1: 15$, TP2: 19$ Mental Stop loss: 10.80$, risk reward ratio is 5 to 1 This is my idea and could be wrong 100%.
Shlong please
Not convinced on bull or bear side. Totally neutral right now. I need more confirmation but here is what I see. We had some decent buying by bulls @ $10.20 which is a critical support level . Bad news for bulls there wasn't any decent buying after that. In my opinion price will break down towards $6.20 -$5.50 range, but If we do show signs of buying pressure,...
I like the repeat of this pattern from October. History of structure; RSI checked down/bounced on the bottom of the bull zone; similar break of counter trendline; reclaimed 8 & 21 EMA. I have a position.
Bull Flag Descending volume PPS above 50MA and 200MA 200MA pointing up ATR pointing up If confirmed Target 1 = 5.12 Target 2 = 5.79 Target 3 = 6.43 Target 4 = 7.76
Cardiff Oncology, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan...